Postdoctoral Fellow-MSH-32076-156 jobs in United States
cer-icon
Apply on Employer Site
company-logo

Mount Sinai Health System · 10 hours ago

Postdoctoral Fellow-MSH-32076-156

Mount Sinai Health System is one of the largest academic medical systems in the New York metro area, and they are seeking a highly motivated postdoc to lead projects aimed at developing myeloid cell targeted therapies for cancer treatment. The role involves performing independent research in cancer therapy, analyzing data, and collaborating with other scientists.

Health CareHospitalMedical
check
H1B Sponsor Likelynote

Responsibilities

To advance the application of macrophage-targeted CAR T cells
To develop improved ways to arm CAR T cells to remodel the tumor microenvironment
To develop technologies to spatially localize remodeling factors in the tumor microenvironment
Perform independent research in the area of cancer therapy, this will include molecular cloning, vector production, cell isolation, and testing in vivo in preclinical models of different cancers
Critically analyze data quality and results, communicate results to scientists and lay people
Write or assist in writing scientific papers and grants
Collaborate closely with other scientists to conduct research

Qualification

ImmunologyGene engineeringCancer treatment developmentMolecular cloningCell isolationData analysisScientific writingCollaboration

Required

Ph.D. required
Experience working in a research laboratory setting

Company

Mount Sinai Health System

company-logo
Mount Sinai Health System delivers integrated medical care, research, and medical education through its network.

H1B Sponsorship

Mount Sinai Health System has a track record of offering H1B sponsorships. Please note that this does not guarantee sponsorship for this specific role. Below presents additional info for your reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (5)
2024 (3)
2023 (26)
2022 (20)
2021 (6)
2020 (20)

Funding

Current Stage
Late Stage
Total Funding
$41.9M
Key Investors
National Institutes of HealthHearst Health Prize.Multiple Myeloma Research Foundation
2024-11-11Grant· $7M
2024-06-06Grant· $0.1M
2023-11-02Grant· $7M

Leadership Team

leader-logo
Vincent Tammaro
Executive Vice President and Chief Financial Officer
linkedin
leader-logo
David Feinberg
Senior Vice President, Chief Marketing and Communications Officer
linkedin
Company data provided by crunchbase